Navigation Links
Investigators predict, confirm how E. coli bacteria hijack cells' directional mechanism
Date:2/29/2012

DALLAS March 1, 2012 Working in the emerging field of systems biology, UT Southwestern Medical Center researchers mathematically predicted how bacteria that cause food poisoning hijack a cell's sense of direction and then confirmed those predictions in living cells.

The study proposed a new model to explain how mammalian cells establish the sense of direction necessary to move, as well as the mechanism that a disease-causing form of E. coli bacteria employ to hijack that ability. Cells need to orient themselves for several basic processes, such as keeping biochemical reactions separated in space and, in the case of immune cells, pursuing pathogens. Importantly, disruption of the cell's sense of direction often leads to human disease.

"This is a great example of scientists from different fields of research coming together to solve a complex and important biological problem," said Dr. Neal Alto, assistant professor of microbiology and senior author of the study, published Feb. 17 in Cell.

Systems biology aims to discover and understand a "circuit theory" for biology a set of powerful and predictive principles that will reveal how networks of biological components are wired to display the complex properties of living things. The rapidly emerging field requires experts in several scientific disciplines including biology, physics, mathematics and computer science to come together to create models of biological systems that consider both the individual parts and how these parts react to each other and to changes in their environment.

Scientists from UT Southwestern's microbiology department and the newly expanded Cecil H. and Ida Green Comprehensive Center for Molecular, Computational and Systems Biology teamed up to examine the problem collaboratively. They initially conceived a mathematical model for their hypothesis of how the cell would respond during an E. coli-induced infection and then tested their computational predictions in living cells.

"Bacteria inject protein molecules into human cells with a needle-and-syringe action," Dr. Alto said. "The human cell responds by producing a local actin-rich membrane protrusion at the spot where the bacteria attaches to the cell."

For healthy cells to move normally, these actin polymers push against a cell's membrane, protruding and propelling the cell in one direction or another. When E. coli molecules are injected, however, actin polymers rush to the site infection and help bacterial molecules both move within the cell and establish an internal site of infection.

Robert Orchard, graduate student of microbiology and the study's lead author, said: "By asking 'How does a bacterial pathogen from outside the cell regulate the host cells' actin dynamics within the cell?' we have uncovered a fundamentally new molecular circuit involved in mammalian cell polarity and bacterial infection. These findings provide new insight into the regulatory mechanisms that control both disease-causing agents and normal mammalian cell behavior."


'/>"/>
Contact: Deborah Wormser
deborah.wormser@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert

Related medicine news :

1. LA BioMed investigators uncover new advancements in cardiovascular medicine
2. Rutgers, Massachusetts General investigators find novel way to prevent drug-induced liver injury
3. LA BioMed investigators lead first survey to determine hospital EDs pediatric readiness
4. Office of Naval Research young investigators honored with Presidential Award
5. NIH program allows junior investigators to bypass traditional post-doc training
6. Insulation from public pressure leads to more accurate suicide reporting by death investigators
7. Damon Runyon Cancer Research Foundation awards $3.45 million to 9 top young clinical investigators
8. Landmark study analyzes scientific productivity and impact of the top 100 PD investigators
9. Investigators explore new frontiers in the development of tomorrows pain medicines
10. NIH investigators find link between DNA damage and immune response
11. Investigators discover enzyme essential for healthy lung development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ... in the greater Dallas, Miami, and Raleigh regions, is organizing an extended charity ... a rare and deadly chromosome abnormality. , After struggling since birth with several ...
(Date:10/13/2017)... Milwaukee, WI (PRWEB) , ... October 13, 2017 , ... ... movement in medicine known as “patient engagement.” The patient is doing more than filling ... research partners. , “There is an increasing emphasis in health care and research ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The American ... to become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer ... Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. ...
(Date:10/13/2017)... Nevada (PRWEB) , ... October 13, 2017 , ... ... Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil ... required and providing a CBD form that can be easily incorporated into liquid products, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder ... of ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership ... rules. It also provides a forum to network with elder law attorneys nationwide,” said ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... -- Halo Labs announces the European launch of their new low ... MIBio 2017 in Cambridge, U.K on October ... biopharmaceutical samples with unprecedented speed and sensitivity while using far less ... Imaging. ... analysis system ...
(Date:9/27/2017)...  Commended for their devotion to personalized service, SMP Pharmacy ... one in the South Florida Business Journal,s 50 Fastest-Growing Companies, ... list, the national specialty pharmacy has found its niche.  To ... soon be honored by SFBJ as the 2017 Power Leader ... to receive his award in October, Bardisa said of the ...
(Date:9/23/2017)... Janssen Biotech, Inc. (Janssen) announced today that ... U.S. Food and Drug Administration (FDA) for the Biologics ... treatment of moderately to severely active rheumatoid arthritis (RA). ... needed to further evaluate the safety of sirukumab in ... "We are disappointed ...
Breaking Medicine Technology: